Research article
Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs
Jan J. Ochnio, David Patrick, Margaret Ho, Douglas N. Talling and Simon R. Dobson
CMAJ August 07, 2001 165 (3) 293-297;
Jan J. Ochnio
From the *Vaccine Evaluation Center, British Columbia's Children's Hospital and the University of British Columbia, and the †University of British Columbia Centre for Disease Control, Vancouver, BC.
David Patrick
From the *Vaccine Evaluation Center, British Columbia's Children's Hospital and the University of British Columbia, and the †University of British Columbia Centre for Disease Control, Vancouver, BC.
Margaret Ho
From the *Vaccine Evaluation Center, British Columbia's Children's Hospital and the University of British Columbia, and the †University of British Columbia Centre for Disease Control, Vancouver, BC.
Douglas N. Talling
From the *Vaccine Evaluation Center, British Columbia's Children's Hospital and the University of British Columbia, and the †University of British Columbia Centre for Disease Control, Vancouver, BC.
Simon R. Dobson
From the *Vaccine Evaluation Center, British Columbia's Children's Hospital and the University of British Columbia, and the †University of British Columbia Centre for Disease Control, Vancouver, BC.
In this issue
Article tools
Respond to this article
Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs
Jan J. Ochnio, David Patrick, Margaret Ho, Douglas N. Talling, Simon R. Dobson
CMAJ Aug 2001, 165 (3) 293-297;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Vaccine-preventable diseases other than tuberculosis, and homelessness: A systematic review of the published literature, 1980 to 2020
- Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth
- Hepatitis A vaccine: Is it being used to best advantage?